These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 3443671)

  • 1. Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine.
    Eichelbaum M; Bertilsson L; Küpfer A; Steiner E; Meese CO
    Br J Clin Pharmacol; 1988 Apr; 25(4):505-8. PubMed ID: 3382592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatographic method for the determination of debrisoquine and its 4-hydroxy metabolite in human urine.
    Róna K; Vereczkey L; Gachályi B
    J Chromatogr; 1986 Jun; 378(2):509-13. PubMed ID: 3734009
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Dixon ST; McLean AJ
    J Chromatogr; 1986 Jan; 374(1):204-8. PubMed ID: 3949931
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of urine pH on debrisoquine phenotyping: application of an HPLC-method.
    Kallio J
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):223-6. PubMed ID: 2163994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine.
    Westwood BE; Harman PJ; Mashford ML
    J Chromatogr; 1986 Jan; 374(1):200-3. PubMed ID: 3949930
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct determination of debrisoquine and 4-hydroxydebrisoquine using a high-performance liquid chromatographic switching technique.
    Decolin D; Nicolas A; Motassim N; Siest G
    J Chromatogr; 1987 Aug; 419():469-74. PubMed ID: 3667807
    [No Abstract]   [Full Text] [Related]  

  • 7. High-performance liquid chromatographic method for the analysis of debrisoquine and its S-(+)- and R-(-)-hydroxy metabolites in urine.
    Meese CO; Thalheimer P; Eichelbaum M
    J Chromatogr; 1987 Dec; 423():344-50. PubMed ID: 3443671
    [No Abstract]   [Full Text] [Related]  

  • 8. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
    Lennard MS; Tucker GT; Woods HF
    Clin Pharmacokinet; 1986; 11(1):1-17. PubMed ID: 2868819
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.